The key factors driving the growth of this market are the growing prevalence of chronic diseases (such as cancer, diabetes, and cardiovascular diseases), favorable reimbursement scenario in major markets, and technological advancements in injector devices.
The global Wearable Injectors Market is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period (2018-2023). Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004 On the basis of type, the wearable injectors market is segmented into on-body and off-body injectors. The on-body injectors segment is expected to account for the larger market share in 2018, while the off-body injectors segment is projected to witness the highest growth rate during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased adoption of off-body injectors. On the basis of therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson’s disease, thalassemia, and primary immunodeficiency disorders). In 2018, the immune-oncology segment is expected to account for the largest share of the wearable injectors market. In 2018, North America is expected to account for the largest share of the wearable injectors market, followed by Europe. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=100771004 The key players in the global wearable injectors market are Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutics Corporation (US), Valeritas (US), and SteadyMed Therapeutics (US). The other prominent players in this market are Ypsomed (Switzerland), Becton, Dickinson and Company (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK).
0 Comments
E-commerce platforms are a tech framework that help company owners control their selling activities digitally. Several market vendors provide various platforms of ecommerce to match various business needs. Each platform has its own benefits and drawbacks, and companies choose the one that fits their needs. E-commerce platforms typically represent the front end aspect of a company and facilitates online selling of goods to the customers.
360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions. Quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the E-Commerce Platforms space. 360Quadrants conducts an in-depth SWOT analysis and accurately analyzes the companies considered for evaluation. This helps service providers in learning about new opportunities and areas where they lag behind their peers. It also helps clients in choosing the most appropriate vendor for their requirements. Know More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms Categorization of E-commerce Platform Providers 360Quadrants evaluated over 35 companies in the E-Commerce Platforms space out of which 19 companies were categorized as Visionary Leaders, Innovators, Dynamic Differentiators, and Emerging Companies. Shopify, WooCommerce, BigCommerce, and Ecwid have been identified as visionary leaders as they have established product portfolios and a robust market presence and business strategies. Shopmatic, Zepo, Zoey, Ecomchain, and Storm have been identified as innovators as they have focused product portfolios, and innovative business strategies which help them in growing consistently. Digital River, Handshake, Kartrocket, and Teespring have been identified as emerging companies as they have niche product offerings and decent business strategies. 2Checkout, Paypro Global, Square E-Commerce, nopCommerce, Sellfy, and Prestashop have been recognized as dynamic differentiators as they are largely dependent on their competitive R&D activities. Factors such as the improving quality of healthcare, improvements in healthcare systems, the growing medical tourism market in Asian countries, and increasing government initiatives are the key factors driving the growth of this market. The benefits of CRM software and a growing focus on patient engagement are the major factors driving the growth of the healthcare CRM market.
The report Healthcare CRM Market is projected to reach USD 17.4 billion by 2023 from USD 8.8 billion in 2018, at a CAGR of 14.6% during the forecast period. Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=88873203 Based on end user, the healthcare CRM market is segmented into healthcare providers, the life sciences industry, and healthcare payers. The healthcare providers segment is estimated to account for the largest share of the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Healthcare providers need to interact with multiple stakeholders, including patients, physicians, other referral healthcare organizations, healthcare payer organizations, pharmaceutical companies, and consumers/potential patients, and each requires unique CRM strategies and solutions. On the basis of component, the healthcare CRM market is segmented into software and services. The services segment is expected to dominate the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Services form a large component of the healthcare CRM market primarily due to the indispensable role of service providers when it comes to the use of CRM solutions for healthcare. Geographically, the global healthcare CRM market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to hold the largest share of the healthcare CRM market. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=88873203 The key players in the healthcare CRM market are Salesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US). Rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support are the key factor driving market growth.
The Molecular Quality Controls Market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523 Based on product type, the molecular controls market is divided into two major segments—instrument-specific controls and independent controls. The independent controls segment accounted for a larger share of the molecular controls market in 2018. The large share of this segment is attributed to the increasing use of third-party independent quality controls due to their benefits such as longer shelf-life and flexible use across different reagent lots, which help reduce the cost of operations. By analyte type, the molecular controls market is segmented into single-analyte controls and multi-analyte controls. Single-analyte controls dominated the molecular controls market in 2018 primarily due to the significant use of singleplex assays in hospitals and the advantages associated with the use of single-analyte controls, such as simple analysis & interpretation and low risk of cross-reactivity. While North America held the largest share of the market in 2018, Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The presence of emerging economies such as China and India and the significant demand for high-quality and accurate diagnostic tests from the large patient population in this region are the major factors supporting the growth of the Asia Pacific molecular quality controls market. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=82625523 The prominent players in the molecular quality controls market are SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). The major factors driving the growth of this market include the growing need to curb increasing healthcare costs and a growing focus on patient-centric care delivery. Moreover, government initiatives for enhancing patient care & safety and government funding for healthcare interoperability are also boosting market growth.
The Healthcare Interoperability Solutions Market is expected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847 Based on type, the healthcare interoperability solutions market is segmented into software and services. The services segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the shifting era towards cloud computing and reduced operational costs for better and faster performance of business processes and applications. Based on software type, the healthcare interoperability solutions market is segmented into EHR interoperability solutions, lab system interoperability solutions, imaging system interoperability solutions, HIE interoperability solutions, enterprise interoperability solutions, and other interoperability solutions. The HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period. North America is expected to account for the largest share of the healthcare interoperability solutions market in 2019, followed by Europe. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=17705847 The prominent players in the healthcare interoperability solutions market are Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), iNTERFACEWARE (Canada), Quality Systems, Inc. (US), OSP Labs (US), Epic Systems Corporation (US), ViSolve, Inc. (US), and Jitterbit (US). The Best e-Commerce platform is a comprehensive software tool that allows merchants to build and manage a digital storefront for their products or services. Because best e-Commerce platforms create a centralized, digital hub for product and customer data, they allow eCommerce businesses to do things like customizing product information, manage web content and layout, allow online transactions to occur, and adjust the platform according to businesses’ online needs.
The global market size of Best E-Commerce Platforms has been estimated at USD 6.5 billion in 2019 and is expected to rise at a compound annual growth rate (CAGR) of 16 per cent between 2020 and 2027. E-commerce tech simplifies complicated procedures and lets firms control their inventory, measure taxes and efficiently handle certain business-related functions. Growing people's embrace of online shopping has contributed to a need for many retailers for e-commerce apps. Read More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms In 2019 the cloud segment had the maximum share of the business. This is due to the growing proliferation of cloud-based technologies through various vertical lines of industry. Cloud-based delivery provides many benefits including flexible computing space, streamlined control, fast performance and redundancy. It is projected that the on-premise market would experience a CAGR of over 6.0 per cent between 2020 and 2027. On-premise installation limits the user's complete control and thus decreases the need for extra security. The delivery process allows the customer complete power over the hardware and the program upgrades. Best E-Commerce Platforms offers hospitals, clinics, and other wellness institutes potential to simplify their buying decision of hospital devices and other supplies. The shift of manufacturing companies of medical devices to digital sites has given market players potential for advancement. Asia Pacific is expected to see the fastest development over the projected period. This recent surge is due to measures in their respective nations carried out by the government of countries like China and India to encourage digitalisation. Due to this, there has been significant growth in internet users. The best E-Commerce Platforms tech industry is highly decentralized and marked by strong global competition, as many market participants perform their business operations across the world. The Best E-Commerce Platforms industry has witnessed numerous strategies of inorganic expansion, such as acquisitions and mergers, alliances, and cooperation that businesses have embraced in the past years. Factors such as the increasing incidence of road accidents and falls, rising geriatric population, and the growing number of joint replacement surgeries are driving the growth of the surgical tourniquets market during the forecast period.
The Surgical Tourniquets Market is projected to grow at a CAGR of 8.0% during the forecast period to reach USD 509 million by 2024 from USD 347 million in 2019. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59028052 The tourniquets systems segment accounted for the largest market share in 2019. This is primarily due to the increasing use of tourniquets system during orthopedic surgeries. In 2018, the US accounted for the largest share of the surgical tourniquet systems market. This is mainly due to the increasing number of joint replacement surgeries in the US. According to the American Joint Replacement Registry (AJRR), 860,080 hip and knee replacement procedures were performed in the US in 2017. This number is expected to reach 3.48 million procedures per year by 2030. The lower-limb surgery segment accounted for the largest share in 2019. This is primarily due to the increasing number of hip & knee replacement surgeries. For instance, as per an article published in Orthopaedic Proceedings Journal (Tourniquet Use for Total Knee Replacement Surgery, February 2018), surgical tourniquets are routinely used by 93% of the surgeons. They are also used in hip replacement procedures and abdominal surgeries. Hospitals and trauma centers are the major end users of surgical tourniquet products. The hospitals and trauma centers segment accounted for the largest share of the surgical tourniquets market in 2018. In 2018, North America dominated the surgical tourniquets market, followed by Europe. The high number of road accidents, a rising number of surgical procedures, and the high & growing number of ambulatory surgery centers are the factors propelling the growth of the market in the region. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=59028052 Prominent players in the surgical tourniquets market are Stryker Corporation (US), Zimmer Biomet (US), ulrich medical (Germany), Hammarplast Medical (Sweden), Delfi Medical Innovations (Canada), VBM Medizintechnik (Germany), Pyng Medical (Canada), Zhangjiagang Huaxin Medical Equipment Factory (China), OHK Medical Devices (Israel), Daesung Maref (Korea), Hangzhou Zhengda Medical Co. (China), Dessillons & Dutrillaux (France), and AneticAid (UK). Metal Implants and Medical Alloys Market worth $17.6 Billion by 2024 explored in latest Research9/23/2020 Market growth is largely driven by the rapidly growing global geriatric population. The elderly are more susceptible to various diseases and disorders such as orthopedic, dental, neurological, and cardiovascular disorders, owing to which, growth in the geriatric population will result in an increase in the demand for implants. The growing number of accidents and sports-related injuries and the increasing launch of technologically advanced products are also major factors supporting market growth.
The global Metal Implants and Medical Alloys Market is projected to reach USD 17.6 billion by 2024 from USD 11.2 billion in 2019, at a CAGR of 9.4%. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256117768 On the basis of type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019. The large share of this segment can be attributed to the advantages offered by titanium, such as high biocompatibility, strength, rigidity, greater strain-bearing capacity, and greater corrosion-resistance properties as compared to other materials. Moreover, it is non-allergic, non-magnetic, and non-radio-opaque, and adheres easily to the bone without any additional coating. Based on application, the metal implants and medical alloys market is segmented into orthopedic, cardiovascular, dental, craniomaxillofacial, and neurological applications. The orthopedic applications segment is expected to grow at the highest CAGR in the metal implants and medical alloys market during the forecast period owing to the growing incidence of orthopedic disorders such as osteoporosis and arthritis, which result in a large patient pool for orthopedic implant procedures. North America is expected to account for the largest share of the metal implants and medical alloys market in 2019, followed by Europe and the Asia Pacific. The large share of North America in the global market can be attributed to the growing aging population and subsequent increase in the prevalence of chronic disorders in North American countries, thereby increasing demand for improved products and treatment services. Speak To Analyst:-https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=256117768 The prominent players in the metal implants and medical alloys market are Carpenter Technology Corporation (US), Royal DSM (Netherlands), Johnson Matthey Plc (UK), ATI Specialty Alloys & Components (US), Ametek Specialty Products (US), Aperam S.A. (Luxembourg), QuesTek Innovations LLC (US), and Fort Wayne Metals (US). Factors such as the growing prevalence of target diseases, the favorable reimbursement scenario in major markets, and advancements in technologies & designs of electronic drug delivery systems are driving the growth of the electronic drug delivery systems market during the forecast period. However, emerging economies such as China, India, Russia, and Brazil offer significant growth opportunities for players in the electronic drug delivery market.
The Electronic Drug Delivery Systems Market is projected to grow at a CAGR of 8.7% during the forecast period to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019. This can primarily be attributed to the diversified healthcare markets in this region, growing incidence of chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165758442 The electronic wearable infusion pumps segment accounted for the largest share of the electronic drug delivery systems market in 2018. This is primarily due to the rising prevalence of diabetes and the increasing availability of commercial infusion pumps for diabetes treatment. However, the high cost of electronic drug delivery devices, high acceptance of conventional devices, and lack of reimbursement for electronic drug delivery devices in developing countries could restrain the growth of this segment. The diabetes segment accounted for the largest share in 2018. This is primarily due to the high prevalence of diabetes across the globe and the greater availability of electronic drug delivery devices, such as insulin pumps and injection pens, for diabetes in comparison to other therapeutic areas. In 2018, North America dominated the electronic drug delivery systems market, followed by Europe. Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=165758442 The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US). E-commerce sites are the most valuable for small to large businesses who offer their goods or services in many countries or industries and have diverse operations. Many of the features mentioned above might not be appropriate for small businesses but some of them may be required for medium-sized companies.
The key goals that E-Commerce sites will help businesses accomplish are to: Manage retail retailers and other associated data such as product specifics and inventory, prices and promotions, consumer addresses, and payment records. Attract customers, and convince them to purchase the company's goods and services. Resolve post-purchase problems such as errors in returns, shipping or payment, and inconsistencies between what customers expected and what they obtained. Track the quantity and profitability of online purchases, as well as lost opportunities including discarded carts. Comply with the electronic protection requirements to stop computer vulnerabilities to cyber threats or theft online. Another important benefit to utilizing best e-Commerce platforms is that it produces a huge amount of data that other applications, such as CRM software, payroll software, Enterprise systems, and supply chain and distribution solutions utilize. For example, detailed sales and return information can be used to determine the company's profitability, how to enhance stock levels, or which buyers are the most valuable and which ones do not generate significant income. With all this intelligence, companies will change their strategies to meet evolving consumer tastes and concentrate on sectors and segments that are most likely to deliver meaningful sales and sustainable income. Know More: - https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |